Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine

Clinical trial NCT06857370 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06857370
Sponsor: CanSino Biologics Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria, Tetanus and Acellular Pertussis

Start date: 2025-03-23
Primary completion: 2026-01-01
Enrollment: 780

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.